GEMS revenues grew in '02
GE Medical Systems achieved 6% revenue growth last year, according to the company's 2002 annual report, released March 7. GEMS reported higher equipment and product services volume, partially offset by weak market conditions in Latin America and Japan.
GE Medical Systems achieved 6% revenue growth last year, according to the company's 2002 annual report, released March 7. GEMS reported higher equipment and product services volume, partially offset by weak market conditions in Latin America and Japan. Revenues were $8.9 billion in 2002, compared with $8.41 billion the previous year. Operating profit was $1.55 billion compared with $1.50 billion in 2001.
FDA Grants Fast Track Designation to Emerging Agent for Brain PET Imaging
June 11th 2025Currently being evaluated in a phase 2b clinical trial, the 18F-RAD101 PET imaging agent garnered the FDA’s fast track designation for distinguishing between recurrent disease and treatment impact for brain metastases derived from solid tumors.
New PSMA PET Prep Product Now Available in the U.S.
June 11th 2025Offering an extended shelf life, the FDA-approved Gozellix, a preparation kit for gallium-68 (68Ga) gozetotide injection, is indicated for use in PSMA PET imaging of prostate cancer patients with suspected recurrence or metastasis.
